HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wella first quarter results

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics and fragrance division sales advanced 6.4% to $117.2 mil. (€1=$.91) in first quarter despite weak markets in travel retail and Germany, Darmstadt, Germany company reports. Yardley of London contributed 5.1% to sales growth, yet lowered operating profit due to start-up costs, company noted. Wella acquired Yardley in December (1"The Rose Sheet" Dec. 17, 2001, p. 8). Consumer division sales grew 3.4% to $214.3 mil., slightly below expectations, Wella says. Professional division sales increased 17.3% to $353.7 mil. in Q1, accounting for over half of overall sales. Consolidated sales climbed 10.8% to $685.3 mil., while net profit was up nearly 18% to $21.8 mil. in first quarter...

You may also be interested in...



Wella Yardley North America Acquisition To Globalize Brand

Wella's acquisition of Yardley of London's North American business from New York City-based Wasserstein & Co. may give the company an opportunity to introduce its European stable of upscale Yardley offerings to the U.S. market, Yardley said

On CRN Challenge, Nexus Formulas Gets Lesson On Supporting Ad Claims For Supplements

So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go its "scope of review" and note unclear instructions on Plavinol labels.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

UsernamePublicRestriction

Register

RS010306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel